Oligomerization of the heptahelical G protein coupling receptors: A case for association using transmembrane helices

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 3, 2009, Pages 329-339

  Parker, M S ^a   Sah, R ^b   Park, E A ^c   Sweatman, T ^c   Balasubramaniam, A ^b   Sallee, F R ^b   Parker, Steven Leonard ^c  

^a UNIVERSITY OF MEMPHIS   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Receptor heterodimer; Receptor homodimer; Receptor oligomer; Rhodopsin like receptor; Signal transduction

Indexed keywords

CELL ENZYME; G PROTEIN COUPLED RECEPTOR; HETERODIMER; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; HOMODIMER; MEMBRANE PROTEIN; MONOMER; OLIGOMER; PROTEINASE; PROTEIN SUBUNIT;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; DIMERIZATION; ENDOPLASMIC RETICULUM; HUMAN; NONHUMAN; OLIGOMERIZATION; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; REVIEW;

ANIMALS; HUMANS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN SUBUNITS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 65349135865     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389557510909030329     Document Type: Article

References (147)

1. Taylor, E.W.; Agarwal, A. Sequence homology between bacteriorhodopsin and G-protein coupled receptors: exon shuffling or evolution by duplication? FEBS Lett., 1993, 325, 161-6.
2. Lin, X.; Tan, S.M.; Law, S.K.; Torres, J. Two types of transmembrane homomeric interactions in the integrin receptor family are evolutionarily conserved. Proteins, 2006, 63, 16-23.
3. Senes, A.; Gerstein, M.; Engelman, D.M. Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with beta-branched residues at neighboring positions. J. Mol. Biol., 2000, 296, 921-36.
4. Filizola, M.; Weinstein, H. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics. FEBS J., 2005, 272, 2926-38.
5. Schwartz, T.W.; Holst, B. Ago-allosteric modulation and other types of allostery in dimeric 7TM receptors. J. Recept. Signal Transduct., 2006, 26, 107-28.
6. Langer, I.; Robberecht, P. Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors. Biochem. Soc. Trans., 2007, 35, 724-8.
7. Milligan, G.; Smith, N.J. Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends Pharmacol. Sci., 2007, 28, 615-20.
8. Pin, J.P.; Neubig, R.; Bouvier, M.; Devi, L.; Filizola, M.; Javitch, J.A.; Lohse, M.J.; Milligan, G.; Palczewski, K.; Parmentier, M.; Spedding, M. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol. Rev., 2007, 59, 5-13.
9. Milligan, G.; Kostenis, E. Heterotrimeric G-proteins: a short history. Br. J. Pharmacol., 2006, 147(Suppl 1), S46-55.
10. Mansoor, S.E.; Palczewski, K.; Farrens, D.L. Rhodopsin self-associates in asolectin liposomes. Proc. Natl. Acad. Sci., USA, 2006, 103, 3060-5.
11. Parker, S.L.; Parker, M.S.; Wong, Y.Y.; Sah, R.; Balasubramaniam, A.; Sallee, F. Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor. Eur. J. Pharmacol., 2008, 594, 26-31.
12. Sugden, D.; Klein, D.C. Rat pineal alpha 1-adrenoceptors: identification and characterization using [125]Iiodo-2-[beta-(4-hydroxyphenyl)-ethylaminomethyltetralone. Endocrinology, 1984, 114, 435-40.
13. Sheikh, S.P.; Sheikh, M.I.; Schwartz, T.W. Y2-type receptors for peptide YY on renal proximal tubular cells in the rabbit. Am. J. Physiol., 1989, 257, F978-84.
14. Fredriksson, R.; Schioth, H.B. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol. Pharmacol., 2005, 67, 1414-25.
15. Reaven, E.; Nomoto, A.; Cortez, Y.; Azhar, S. Consequences of over-expression of rat Scavenger Receptor, SR-BI, in an adrenal cell model. Nutr. Metab. (London), 2006, 3, 43.
16. Small, K.M.; Schwarb, M.R.; Glinka, C.; Theiss, C.T.; Brown, K.M.; Seman, C.A.; Liggett, S.B. Alpha2A- and alpha2C-adrenergic receptors form homo- and heterodimers: the heterodimeric state impairs agonist-promoted GRK phosphorylation and beta-arrestin recruitment. Biochemistry, 2006, 45, 4760-7.
17. Angers, S.; Salahpour, A.; Joly, E.; Hilairet, S.; Chelsky, D.; Dennis, M.; Bouvier, M. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci., USA, 2000, 97, 3684-9.
18. Berglund, M.M.; Schober, D.A.; Esterman, M.A.; Gehlert, D.R. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J. Pharmacol. Exp. Ther., 2003, 307, 1120-6.
19. Ramsay, D.; Carr, I.C.; Pediani, J.; Lopez-Gimenez, J.F.; Thurlow, R.; Fidock, M.; Milligan, G. High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1Ladrenoceptor. Mol. Pharmacol., 2004, 66, 228-39.
20. van Rijn, R.M.; Chazot, P.L.; Shenton, F.C.; Sansuk, K.; Bakker, R.A.; Leurs, R. Oligomerization of recombinant and endogenously expressed human histamine H(4) receptors. Mol. Pharmacol., 2006, 70, 604-15.
21. Horn, F.; Vriend, G.; Cohen, F.E. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res., 2001, 29, 346-9.
22. McMillan, D.R.; Kayes-Wandover, K.M.; Richardson, J.A.; White, P.C. Very large G protein-coupled receptor-1, the largest known cell surface protein, is highly expressed in the developing central nervous system. J. Biol. Chem., 2002, 277, 785-92.
23. McGee, J.; Goodyear, R.J.; McMillan, D.R.; Stauffer, E.A.; Holt, J.R.; Locke, K.G.; Birch, D.G.; Legan, P.K.; White, P.C.; Walsh, E.J.; Richardson, G.P. The very large G-protein-coupled receptor VLGR1: a component of the ankle link complex required for the normal development of auditory hair bundles. J. Neurosci., 2006, 26, 6543-53.
24. Horn, F.; Bettler, E.; Oliveira, L.; Campagne, F.; Cohen, F.E.; Vriend, G. GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res., 2003, 31, 294-7.
25. Kniazeff, J.; Galvez, T.; Labesse, G.; Pin, J.P. No ligand binding in the GB2 subunit of the GABA(B) receptor is required for activation and allosteric interaction between the subunits. J. Neurosci., 2002, 22, 7352-61.
26. Parker, M.S.; Sah, R.; Balasubramaniam, A.; Sallee, F.R.; Par, E.A.; Sweatman, T.; Parker, S.L. Dimers of the neuropeptide Y (NPY) Y2 receptor show asymmetry in agonist affinity and association with G-proteins. J. Recept. Signal Transduct., 2008, 28, 437-51.
27. Avlani, V.A.; Gregory, K.J.; Morton, C.J.; Parker, M.W.; Sexton, P.M.; Christopoulos, A. Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G proteincoupled receptor ligands. J. Biol. Chem., 2007, 282, 25677-86.
28. Rothman, R.B.; Murphy, D.L.; Xu, H.; Godin, J.A.; Dersch, C.M.; Partilla, J.S.; Tidgewell, K.; Schmidt, M.; Prisinzano, T.E. Salvinorin A: allosteric interactions at the mu-opioid receptor. J. Pharmacol. Exp. Ther., 2007, 320, 801-10.
29. Rutherford, J.M.; Wang, J.; Xu, H.; Dersch, C.M.; Partilla, J.S.; Rice, K.C.; Rothman, R.B. Evidence for a mu-delta opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors. Peptides, 2008, 29, 1424-31.
30. Ernst, O.P.; Gramse, V.; Kolbe, M.; Hofmann, K.P.; Heck, M. Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit. Proc. Natl. Acad. Sci., USA, 2007, 104, 10859-64.
31. Whorton, M.R.; Jastrzebska, B.; Park, P.S.; Fotiadis, D.; Engel, A.; Palczewski, K.; Sunahara, R.K. Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J. Biol. Chem., 2008, 283, 4387-94.
32. Parker, S.L.; Parker, M.S.; Estes, M.A.; Wong, Y.Y.; Sah, R.; Sweatman, T.; Park, E.A.; Balasubramaniam, A.; Sallee, F.R. The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebrain. J. Recept. Signal Transduct., 2008, 28, 245-63.
33. Baneres, J.L.; Parello, J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J. Mol. Biol., 2003, 329, 815-29.
34. Guo, W.; Shi, L.; Filizola, M.; Weinstein, H.; Javitch, J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc. Natl. Acad. Sci., USA, 2005, 102, 17495-500.
35. Palczewski, K. G protein-coupled receptor rhodopsin. Annu. Rev. Biochem., 2006, 75, 743-67.
36. Kniazeff, J.; Bessis, A.S.; Maurel, D.; Ansanay, H.; Prezeau, L.; Pin, J.P. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat. Struct. Mol. Biol., 2004, 11, 706-13.
37. Damian, M.; Martin, A.; Mesnier, D.; Pin, J.P.; Baneres, J.L. Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J., 2006, 25, 5693-702.
38. Stryer, L. Transducin and the cyclic GMP phosphodiesterase: amplifier proteins in vision. Cold Spring Harbor Symp. Quant. Biol., 1983, 48, 841-52.
39. Filizola, M.; Wang, S.X.; Weinstein, H. Dynamic models of G-protein coupled receptor dimers: indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer. J. Comput. Aided Mol. Des., 2006, 20, 405-16.
40. Kim, S.K.; Jacobson, K.A. Computational prediction of homodimerization of the A3 adenosine receptor. J. Mol. Graph. Model., 2006, 25, 549-61.
41. Mancia, F.; Assur, Z.; Herman, A.G.; Siegel, R.; Hendrickson, W.A. Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor. EMBO Rep., 2008, 9, 363-9.
42. Hernanz-Falcon, P.; Rodriguez-Frade, J.M.; Serrano, A.; Juan, D.; del Sol, A.; Soriano, S.F.; Roncal, F.; Gomez, L.; Valencia, A.; Martinez, A.C.; Mellado, M. Identification of amino acid residues crucial for chemokine receptor dimerization. Nat. Immunol., 2004, 5, 216-23.
43. Vohra, S.; Chintapalli, S.V.; Illingworth, C.J.; Reeves, P.J.; Mullineaux, P.M.; Clark, H.S.; Dean, M.K.; Upton, G.J.; Reynolds, C.A. Computational studies of Family A and Family B GPCRs. Biochem. Soc. Trans., 2007, 35, 749-54.
44. Terrillon, S.; Durroux, T.; Mouillac, B.; Breit, A.; Ayoub, M.A.; Taulan, M.; Jockers, R.; Barberis, C.; Bouvier, M. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol. Endocrinol., 2003, 17, 677-91.
45. Dupre, D.J.; Robitaille, M.; Ethier, N.; Villeneuve, L.R.; Mamarbachi, A.M.; Hebert, T.E. Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking. J. Biol. Chem., 2006, 281, 34561-73.
46. Nobles, M.; Benians, A.; Tinker, A. Heterotrimeric G proteins precouple with G protein-coupled receptors in living cells. Proc. Natl. Acad. Sci., USA, 2005, 102, 18706-11.
47. Parker, S.L.; Parker, M.S.; Sah, R.; Sallee, F.R.; Balasubramaniam, A. Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin. Regul. Pept., 2007, 139, 128-35.
48. Liang, Y.; Fotiadis, D.; Filipek, S.; Saperstein, D.A.; Palczewski, K.; Engel, A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem., 2003, 278, 21655-62.
49. Urizar, E.; Montanelli, L.; Loy, T.; Bonomi, M.; Swillens, S.; Gales, C.; Bouvier, M.; Smits, G.; Vassart, G.; Costagliola, S. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J., 2005, 24, 1954-64.
50. Robbins, M.J.; Ciruela, F.; Rhodes, A.; McIlhinney, R.A. Characterization of the dimerization of metabotropic glutamate receptors using an N-terminal truncation of mGluR1alpha. J. Neurochem., 1999, 72, 2539-47.
51. Jensen, A.A.; Hansen, J.L.; Sheikh, S.P.; Brauner-Osborne, H. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). Eur. J. Biochem., 2002, 269, 5076-87.
52. Pace, A.J.; Gama, L.; Breitwieser, G.E. Dimerization of the calcium-sensing receptor occurs within the extracellular domain and is eliminated by Cys -> Ser mutations at Cys101 and Cys236. J. Biol. Chem., 1999, 274, 11629-34.
53. Pidasheva, S.; Grant, M.; Canaff, L.; Ercan, O.; Kumar, U.; Hendy, G.N. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly. Hum. Mol. Genet., 2006, 15, 2200-9.
54. Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P., Molecular Biology of the Cell, 4th ed. Garland Science: New York, 2002; chapter 12, pp. 659-710.
55. Li, R.; Gorelik, R.; Nanda, V.; Law, P.B.; Lear, J.D.; DeGrado, W.F.; Bennett, J.S. Dimerization of the transmembrane domain of Integrin alphaIIb subunit in cell membranes. J. Biol. Chem., 2004, 279, 26666-73.
56. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Le Trong, I.; Teller, D.C.; Okada, T.; Stenkamp, R.E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science, 2000, 289, 739-45.
57. Adamian, L.; Jackups, R., Jr.; Binkowski, T.A.; Liang, J. Higher-order interhelical spatial interactions in membrane proteins. J. Mol. Biol., 2003, 327, 251-72.
58. Lopez-Gimenez, J.F.; Canals, M.; Pediani, J.D.; Milligan, G. The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol. Pharmacol., 2007, 71, 1015-29.
59. Kota, P.; Reeves, P.J.; Rajbhandary, U.L.; Khorana, H.G. Opsin is present as dimers in COS1 cells: identification of amino acids at the dimeric interface. Proc. Natl. Acad. Sci., USA, 2006, 103, 3054-9.
60. Harikumar, K.G.; Dong, M.; Cheng, Z.; Pinon, D.I.; Lybrand, T.P.; Miller, L.J. Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function. Biochemistry, 2006, 45, 14706-16.
61. Fotiadis, D.; Liang, Y.; Filipek, S.; Saperstein, D.A.; Engel, A.; Palczewski, K. Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature, 2003, 421, 127-8.
62. Muly, E.C.; Maddox, M.; Smith, Y. Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex. J. Comp. Neurol., 2003, 467, 521-35.
63. Salahpour, A.; Angers, S.; Mercier, J.F.; Lagace, M.; Marullo, S.; Bouvier, M. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J. Biol. Chem., 2004, 279, 33390-7.
64. Herrick-Davis, K.; Weaver, B.A.; Grinde, E.; Mazurkiewicz, J.E. Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer. J. Biol. Chem., 2006, 281, 27109-16.
65. Parker, S.L.; Parker, M.S.; Sah, R.; Balasubramaniam, A.; Sallee, F.R. Pertussis toxin induces parallel loss of neuropeptide Y Y(1) receptor dimers and G(i) alpha subunit function in CHO cells. Eur. J. Pharmacol., 2008, 579, 13-25.
66. Steiner, T.; Koellner, G. Hydrogen bonds with pi-acceptors in proteins: frequencies and role in stabilizing local 3D structures. J. Mol. Biol., 2001, 305, 535-57.
67. Noordeen, N.A.; Carafoli, F.; Hohenester, E.; Horton, M.A.; Leitinger, B. A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1. J. Biol. Chem., 2006, 281, 22744-51.
68. Berthouze, M.; Rivail, L.; Lucas, A.; Ayoub, M.A.; Russo, O.; Sicsic, S.; Fischmeister, R.; Berque-Bestel, I.; Jockers, R.; Lezoualc'h, F. Two transmembrane Cys residues are involved in 5-HT4 receptor dimerization. Biochem. Biophys. Res. Commun., 2007, 356, 642-7.
69. Luna, R.; Jimeno, S.; Marin, M.; Huertas, P.; Garcia-Rubio, M.; Aguilera, A. Interdependence between transcription and mRNP processing and export, and its impact on genetic stability. Mol. Cell, 2005, 18, 711-22.
70. Carrillo, J.J.; Lopez-Gimenez, J.F.; Milligan, G. Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor. Mol. Pharmacol., 2004, 66, 1123-37.
71. North, B.; Cristian, L.; Fu Stowell, X.; Lear, J.D.; Saven, J.G.; Degrado, W.F. Characterization of a membrane protein folding motif, the Ser zipper, using designed peptides. J. Mol. Biol., 2006, 359, 930-9.
72. Cheng, Z.J.; Miller, L.J. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J. Biol. Chem., 2001, 276, 48040-7.
73. Grant, M.; Collier, B.; Kumar, U. Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking. J. Biol. Chem., 2004, 279, 36179-83.
74. Parker, S.L.; Parker, M.S.; Sallee, F.R.; Balasubramaniam, A. Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins. Regul. Pept., 2007, 144, 72-81.
75. Pearson, W.R. Flexible sequence similarity searching with the FASTA3 program package. Methods Mol. Biol., 2000, 132, 185-219.
76. Senes, A.; Ubarretxena-Belandia, I.; Engelman, D.M. The Calpha - - H...O hydrogen bond: a determinant of stability and specificity in transmembrane helix interactions. Proc. Natl. Acad. Sci., USA, 2001, 98, 9056-61.
77. Behncken, S.N.; Billestrup, N.; Brown, R.; Amstrup, J.; Conway-Campbell, B.; Waters, M.J. Growth hormone (GH)-independent dimerization of GH receptor by a leucine zipper results in constitutive activation. J. Biol. Chem., 2000, 275, 17000-7.
78. Gray, T.M.; Matthews, B.W. Intrahelical hydrogen bonding of serine, threonine and cysteine residues within alpha-helices and its relevance to membrane-bound proteins. J. Mol. Biol., 1984, 175, 75-81.
79. Hislop, J.N.; Caunt, C.J.; Sedgley, K.R.; Kelly, E.; Mundell, S.; Green, L.D.; McArdle, C.A. Internalization of gonadotropin-releasing hormone receptors (GnRHRs): does arrestin binding to the C-terminal tail target GnRHRs for dynamin-dependent internalization? J Mol. Endocrinol., 2005, 35, 177-89.
80. Schulte, G.; Bryja, V. The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol. Sci., 2007, 28, 518-25.
81. Silve, C.; Petrel, C.; Leroy, C.; Bruel, H.; Mallet, E.; Rognan, D.; Ruat, M. Delineating a Ca2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. J. Biol. Chem., 2005, 280, 37917-23.
82. Felder, C.B.; Graul, R.C.; Lee, A.Y.; Merkle, H.P.; Sadee, W. The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors. AAPS PharmSci., 1999, 1, 1-14.
83. Cai, K.; Klein-Seetharaman, J.; Altenbach, C.; Hubbell, W.L.; Khorana, H.G. Probing the dark state tertiary structure in the cytoplasmic domain of rhodopsin: proximities between amino acids deduced from spontaneous disulfide bond formation between cysteine pairs engineered in cytoplasmic loops 1, 3, and 4. Biochemistry, 2001, 40, 12479-85.
84. Miller, L.J.; Dong, M.; Harikumar, K.G.; Gao, F. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor. Biochem. Soc. Trans., 2007, 35, 709-12.
85. Mann, R.; Nasr, N.; Hadden, D.; Sinfield, J.; Abidi, F.; Al-Sabah, S.; de Maturana, R.L.; Treece-Birch, J.; Willshaw, A.; Donnelly, D. Peptide binding at the GLP-1 receptor. Biochem. Soc. Trans., 2007, 35, 713-6.
86. Zhang, R.; Buczko, E.; Dufau, M.L. Requirement of cysteine residues in exons 1-6 of the extracellular domain of the luteinizing hormone receptor for gonadotropin binding. J. Biol. Chem., 1996, 271, 5755-60.
87. Hu, J.; Hauache, O.; Spiegel, A.M. Human Ca2+ receptor cysteine-rich domain. Analysis of function of mutant and chimeric receptors. J. Biol. Chem., 2000, 275, 16382-9.
88. Suga, H.; Schmid, V.; Gehring, W.J. Evolution and functional diversity of jellyfish opsins. Curr. Biol., 2008, 18, 51-55.
89. Brandt, W.; Golbraikh, A.; Tager, M.; Lendeckel, U. A molecular mechanism for the cleavage of a disulfide bond as the primary function of agonist binding to G-protein-coupled receptors based on theoretical calculations supported by experiments. Eur. J. Biochem., 1999, 261, 89-97.
90. McKibbin, C.; Toye, A.M.; Reeves, P.J.; Khorana, H.G.; Edwards, P.C.; Villa, C.; Booth, P.J. Opsin stability and folding: the role of Cys185 and abnormal disulfide bond formation in the intradiscal domain. J. Mol. Biol., 2007, 374, 1309-18.
91. Zeng, F.Y.; Wess, J. Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem., 1999, 274, 19487-97.
92. Kurtenbach, E.; Curtis, C.A.; Pedder, E.K.; Aitken, A.; Harris, A.C.; Hulme, E.C. Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. J. Biol. Chem., 1990, 265, 13702-8.
93. Davidson, J.S.; Assefa, D.; Pawson, A.; Davies, P.; Hapgood, J.; Becker, I.; Flanagan, C.; Roeske, R.; Millar, R. Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment. Biochemistry, 1997, 36, 12881-9.
94. Swift, S.; Leger, A.J.; Talavera, J.; Zhang, L.; Bohm, A.; Kuliopulos, A. Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism. J. Biol. Chem., 2006, 281, 4109-16.
95. Sadeghi, H.M.; Innamorati, G.; Dagarag, M.; Birnbaumer, M. Palmitoylation of the V2 vasopressin receptor. Mol. Pharmacol., 1997, 52, 21-9.
96. DeSouza, S.; Fu, J.; States, B.A.; Ziff, E.B. Differential palmitoylation directs the AMPA receptor-binding protein ABP to spines or to intracellular clusters. J. Neurosci., 2002, 22, 3493-503.
97. Hebert, T.E. Opioid and chemokine receptor heterodimers: arranged marriages or dangerous liaisons? Biochem. J., 2008, 412, 245-56.
98. Scott, L.; Zelenin, S.; Malmersjo, S.; Kowalewski, J.M.; Markus, E.Z.; Nairn, A.C.; Greengard, P.; Brismar, H.; Aperia, A. Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines. Proc. Natl. Acad. Sci., USA, 2006, 103, 762-7.
99. Bose, S.; Chapin, S.J.; Seetharam, S.; Feix, J.; Mostov, K.E.; Seetharam, B. Brefeldin A (BFA) inhibits basolateral membrane (BLM) delivery and dimerization of transcobalamin II receptor in human intestinal epithelial Caco-2 cells. BFA effects on BLM cholesterol content. J. Biol. Chem., 1998, 273, 16163-9.
100. Dahms, N.M.; Kornfeld, S. The cation-dependent mannose 6-phosphate receptor. Structural requirements for mannose 6-phosphate binding and oligomerization. J. Biol. Chem., 1989, 264, 11458-67.
101. Saarela, J.; Laine, M.; Oinonen, C.; Schantz, C.; Jalanko, A.; Rouvinen, J.; Peltonen, L. Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations. Hum. Mol. Genet., 2001, 10, 983-95.
102. Garman, S.C.; Garboczi, D.N. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J. Mol. Biol., 2004, 337, 319-35.
103. Linglart, A.; Mahon, M.J.; Kerachian, M.A.; Berlach, D.M.; Hendy, G.N.; Juppner, H.; Bastepe, M. Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3′,5′-monophosphate formation mediated by human XLalphas. Endocrinology, 2006, 147, 2253-62.
104. Young, L.T.; Warsh, J.J.; Li, P.P.; Siu, K.P.; Becker, L.; Gilbert, J.; Hornykiewicz, O.; Kish, S.J. Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain. Brain Res. Dev. Brain Res., 1991, 61, 243-8.
105. Pello, O.M.; Martinez-Munoz, L.; Parrillas, V.; Serrano, A.; Rodriguez-Frade, J.M.; Toro, M.J.; Lucas, P.; Monterrubio, M.; Martinez, A.C.; Mellado, M. Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur. J. Immunol., 2008, 38, 537-49.
106. Cheng, Z.J.; Harikumar, K.G.; Holicky, E.L.; Miller, L.J. Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth. J. Biol. Chem., 2003, 278, 52972-9.
107. Li, E.; You, M.; Hristova, K. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation. J. Mol. Biol., 2006, 356, 600-12.
108. Mellado, M.; Rodriguez-Frade, J.M.; Vila-Coro, A.J.; Fernandez, S.; Martin de Ana, A.; Jones, D.R.; Toran, J.L.; Martinez, A.C. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J., 2001, 20, 2497-507.
109. Belshaw, P.J.; Ho, S.N.; Crabtree, G.R.; Schreiber, S.L. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc. Natl. Acad. Sci., USA, 1996, 93, 4604-7.
110. Herrick-Davis, K.; Grinde, E.; Harrigan, T.J.; Mazurkiewicz, J.E. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein. J. Biol. Chem., 2005, 280, 40144-51.
111. Soulier, J.L.; Russo, O.; Giner, M.; Rivail, L.; Berthouze, M.; Ongeri, S.; Maigret, B.; Fischmeister, R.; Lezoualc'h, F.; Sicsic, S.; Berque-Bestel, I. Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies. J. Med. Chem., 2005, 48, 6220-8.
112. Russo, O.; Berthouze, M.; Giner, M.; Soulier, J.L.; Rivail, L.; Sicsic, S.; Lezoualc'h, F.; Jockers, R.; Berque-Bestel, I. Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers. J. Med. Chem., 2007, 50, 4482-92.
113. Stanasila, L.; Perez, J.B.; Vogel, H.; Cotecchia, S. Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J. Biol. Chem., 2003, 278, 40239-51.
114. Carrillo, J.J.; Pediani, J.; Milligan, G. Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J. Biol. Chem., 2003, 278, 42578-87.
115. Milligan, G.; Wilson, S.; Lopez-Gimenez, J.F. The specificity and molecular basis of alpha1-adrenoceptor and CXCR chemokine receptor dimerization. J. Mol. Neurosci., 2005, 26, 161-8.
116. Gouldson, P.R.; Snell, C.R.; Bywater, R.P.; Higgs, C.; Reynolds, C.A. Domain swapping in G-protein coupled receptor dimers. Protein Eng., 1998, 11, 1181-93.
117. Mercier, J.F.; Salahpour, A.; Angers, S.; Breit, A.; Bouvier, M. Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem., 2002, 277, 44925-31.
118. Ng, G.Y.; O'Dowd, B.F.; Lee, S.P.; Chung, H.T.; Brann, M.R.; Seeman, P.; George, S.R. Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem. Biophys. Res. Commun., 1996, 227, 200-4.
119. Guo, W.; Shi, L.; Javitch, J.A. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J. Biol. Chem., 2003, 278, 4385-8.
120. George, S.R.; Lee, S.P.; Varghese, G.; Zeman, P.R.; Seeman, P.; Ng, G.Y.; O'Dowd, B.F. A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J. Biol. Chem., 1998, 273, 30244-8.
121. Kong, M.M.; Fan, T.; Varghese, G.; O'Dowd B, F.; George, S.R. Agonist-induced cell surface trafficking of an intracellularly sequestered D1 dopamine receptor homo-oligomer. Mol. Pharmacol., 2006, 70, 78-89.
122. O'Dowd, B.F.; Ji, X.; Alijaniaram, M.; Rajaram, R.D.; Kong, M.M.; Rashid, A.; Nguyen, T.; George, S.R. Dopamine receptor oligomerization visualized in living cells. J. Biol. Chem., 2005, 280, 37225-35.
123. Fukushima, Y.; Asano, T.; Saitoh, T.; Anai, M.; Funaki, M.; Ogihara, T.; Katagiri, H.; Matsuhashi, N.; Yazaki, Y.; Sugano, K. Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells. FEBS Lett., 1997, 409, 283-6.
124. Bakker, R.A.; Dees, G.; Carrillo, J.J.; Booth, R.G.; Lopez-Gimenez, J.F.; Milligan, G.; Strange, P.G.; Leurs, R. Domain swapping in the human histamine H1 receptor. J. Pharmacol. Exp. Ther., 2004, 311, 131-8.
125. Kang, Y.K.; Yoon, T.; Lee, K.; Kim, H.J. Homo- or heterodimerization of muscarinic receptor subtypes is not mediated by direct protein-protein interaction through intracellular and extracellular regions. Arch. Pharm. Res., 2003, 26, 846-54.
126. Goin, J.C.; Nathanson, N.M. Quantitative analysis of muscarinic acetylcholine receptor homo- and heterodimerization in live cells: regulation of receptor down-regulation by heterodimerization. J. Biol. Chem., 2006, 281, 5416-25.
127. Giguere, V.; Gallant, M.A.; de Brum-Fernandes, A.J.; Parent, J.L. Role of extracellular cysteine residues in dimerization/oligomerization of the human prostacyclin receptor. Eur. J. Pharmacol., 2004, 494, 11-22.
128. Klco, J.M.; Lassere, T.B.; Baranski, T.J. C5a receptor oligomerization. I. Disulfide trapping reveals oligomers and potential contact surfaces in a G protein-coupled receptor. J. Biol. Chem., 2003, 278, 35345-53.
129. Trettel, F.; Di Bartolomeo, S.; Lauro, C.; Catalano, M.; Ciotti, M.T.; Limatola, C. Ligand-independent CXCR2 dimerization. J. Biol. Chem., 2003, 278, 40980-8.
130. Limatola, C.; Di Bartolomeo, S.; Catalano, M.; Trettel, F.; Fucile, S.; Castellani, L.; Eusebi, F. Cysteine residues are critical for chemokine receptor CXCR2 functional properties. Exp. Cell Res., 2005, 307, 65-75.
131. Babcock, G.J.; Farzan, M.; Sodroski, J. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J. Biol. Chem., 2003, 278, 3378-85.
132. Chelli, M.; Alizon, M. Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor. J. Biol. Chem., 2002, 277, 39388-96.
133. Chen, C.; Li, J.; Bot, G.; Szabo, I.; Rogers, T.J.; Liu-Chen, L.Y. Heterodimerization and cross-desensitization between the muopioid receptor and the chemokine CCR5 receptor. Eur. J. Pharmacol., 2004, 483, 175-86.
134. Canals, M.; Burgueno, J.; Marcellino, D.; Cabello, N.; Canela, E.I.; Mallol, J.; Agnati, L.; Ferre, S.; Bouvier, M.; Fuxe, K.; Ciruela, F.; Lluis, C.; Franco, R. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Neurochem., 2004, 88, 726-34.
135. Thevenin, D.; Lazarova, T.; Roberts, M.F.; Robinson, C.R. Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor. Protein Sci., 2005, 14, 2177-86.
136. Lukasiewicz, S.; Blasiak, E.; Faron-Gorecka, A.; Polit, A.; Tworzydlo, M.; Gorecki, A.; Wasylewski, Z.; Dziedzicka-Wasylewska, M. Fluorescence studies of homooligomerization of adenosine A(2A) and serotonin 5-HT(1A) receptors reveal the specificity of receptor interactions in the plasma membrane. Pharmacol. Rep., 2007, 59, 379-92.
137. Philip, F.; Sengupta, P.; Scarlata, S. Signaling through a G Protein-coupled receptor and its corresponding G protein follows a stoichiometrically limited model. J. Biol. Chem., 2007, 282, 19203-16.
138. Hanson, S.M.; Gurevich, E.V.; Vishnivetskiy, S.A.; Ahmed, M.R.; Song, X.; Gurevich, V.V. Each rhodopsin molecule binds its own arrestin. Proc. Natl. Acad. Sci., USA, 2007, 104, 3125-8.
139. Thomas, R.M.; Nechamen, C.A.; Mazurkiewicz, J.E.; Muda, M.; Palmer, S.; Dias, J.A. Follicle-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing. Endocrinology, 2007, 148, 1987-95.
140. Latif, R.; Graves, P.; Davies, T.F. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J. Biol. Chem., 2002, 277, 45059-67.
141. Kern, A.; Hubbard, D.; Amano, A.; Bryant-Greenwood, G.D. Cloning, expression, and functional characterization of relaxin receptor (leucine-rich repeat-containing G protein-coupled receptor 7) splice variants from human fetal membranes. Endocrinology, 2008, 149, 1277-94.
142. Devost, D.; Zingg, H.H. Homo- and hetero-dimeric complex formations of the human oxytocin receptor. J. Neuroendocrinol., 2004, 16, 372-7.
143. Rocheville, M.; Lange, D.C.; Kumar, U.; Sasi, R.; Patel, R.C.; Patel, Y.C. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem., 2000, 275, 7862-9.
144. Pfeiffer, M.; Koch, T.; Schroder, H.; Klutzny, M.; Kirscht, S.; Kreienkamp, H.J.; Hollt, V.; Schulz, S. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J. Biol. Chem., 2001, 276, 14027-36.
145. Dinger, M.C.; Bader, J.E.; Kobor, A.D.; Kretzschmar, A.K.; Beck-Sickinger, A.G. Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells. J. Biol. Chem., 2003, 278, 10562-71.
146. Ding, W.Q.; Cheng, Z.J.; McElhiney, J.; Kuntz, S.M.; Miller, L.J. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Res., 2002, 62, 5223-9.
147. Lisenbee, C.S.; Miller, L.J. Secretin receptor oligomers form intracellularly during maturation through receptor core domains. Biochemistry, 2006, 45, 8216-26.